fda tirzepatide ban The Impact of New Regulations on fda bans compounded semaglutide and

Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression

Because BCBSMA administers two of the City of Bostons employee health plans, coverage for GLP-1 medications used for weight loss will be eliminated for city employees enrolled in those plans as of June 1, 2026

A prior history of gut disorders, such as inflammatory bowel disease, might suggest retatrutide or Ozempic is not safe or will require additional monitoring

That observation ultimately reshaped the trajectory of the entire drug class, leading to obesity-specific formulations and, more recently, FDA approvals for additional chronic conditions

Zepbound works by blocking the absorption of certain types of fat in the digestive tract, which may lead to weight loss in some people